About: http://webisa.webdatacommons.org/426356403

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	The therapy is intended for patients with relapsing-remitting forms of MS and is currently under review by regulatory authorities in Europe, the US, Australia, Canada and Switzerland.
http://www.w3.org/ns/prov#wasQuotedFrom	zenopa.com